Detail of the clinical trial
| Title of the trial | An open label, multicenter study investigating the safety and efficacy of ofatumumab therapy versus physicians´choice in patients with bulky fludarabine refractory chronic lymphocytic leukaemia (CLL) |
|---|---|
| EudraCT number | 2010-023066-52 |
| Protocol number | OMB114242 |
| Sponsor | GlaxoSmithKline Research and Development Ltd, Uxbridge, United Kingdom |
| Indications | Hemato-oncology |
| Diagnosis | chronic lymphocytic leukemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2011 |
| Date of approval by Institute (SÚKL) | 25.3.2011 |
| Date of approval by EC | 17.3.2011 |
| Date of initiation CT in ČR | |
| Date of ending CT in ČR | 2.5.2013 |
| Notice | |
| Sites |
2. interní klinika - odd. klinické hematologie, FN Hradec Králové 1. interní klinika - VFN Praha 2 Hematoonkologická klinika, FN Olomouc |
cz